Specializes in developing and commercializing innovative diagnostic technologies. Focuses on enhancing early detection and management of various health conditions. Operates primarily within the in-vitro diagnostics (IVD) sector, targeting clinical laboratories and healthcare providers. Leverages proprietary platform technologies to create novel assays and testing solutions. Aims to improve patient outcomes through more accurate and timely diagnoses. Actively seeks partnerships with research institutions and commercial entities to expand product offerings and market reach. Recent initiatives include expanding distribution networks in key international markets and advancing clinical trials for lead diagnostic candidates.